1st Recommendations of Ovarian Cancer held in Paris the 30th of march 2012, continues…

AVASTIN AND TARGETED THERAPIES

J. Alexandre, F. Joly, C. Lhommé, F. Selle, E. Pujade – Lauraine, H. Curé

Continuing the discussion : debatreco@arcagy.org

WHAT KIND OF FOLLOW-UP?

Anne-Claire Hardy Bessard (St Brieuc), Patricia Pautier (Villejuif),
Dominique Berton‐Rigaud (Nantes), Nadine Dohollou (Bordeaux)

Continuing the discussion : debatreco@arcagy.org

OVARIAN CANCER IN ELDERLY WOMEN

Claire FALANDRY, Michel FABBRO, Olivier GUERIN, Jean-Emmanuel KURTZ, Anne LESOIN

Continuing the discussion : debatreco@arcagy.org

SURGICAL MANAGEMENT & NEOADJUVANT CHEMOTHERAPY STAGE III-IV OVARIAN CANCER

JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru

Continuing the discussion : debatreco@arcagy.org

CHEMOTHERAPY AFTER FIRST LINE TREATMENT

Paul Cottu, Anne Floquet, Jean-Paul Guastalla, Alain Lortholary, Béatrice Weber

Continuing the discussion : debatreco@arcagy.org


Mise à jour 05/02/2016


icone ARCAGY - GINECO Bookmark and Share imprimante [Imprimer la page] - Association ARCAGY - GINECO - Hôpital Hôtel Dieu